Several studies have shown that Lcn2 expression is upregulated in various pathological conditions such as neurodegeneration, gliomas, brain injury, neuroinflammation, autoimmune disorders, encephalitis, hemorrhage, schizophrenia, and spinal cord injury (Reviewed by Jha et al., 2015). This evidence concerns the gene LCN2 and autoimmune disease.